Pkd1 and Pkd2 are required for normal placental development

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-12

  Garcia Gonzalez, Miguel A ^a,b   Outeda, Patricia ^a   Zhou, Qin ^a,c   Zhou, Fang ^a,d   Menezes, Luis F ^a,d   Qian, Feng ^a   Huso, David L ^a   Germino, Gregory G ^a,d   Piontek, Klaus B ^a   Watnick, Terry ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c SICHUAN UNIVERSITY   (China)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; POLYCYSTIN 1; POLYCYSTIN 2; POLYCYSTIC KIDNEY DISEASE 1 PROTEIN; POLYCYSTIC KIDNEY DISEASE 2 PROTEIN; POLYCYSTIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; EMBRYO; EMBRYO DEATH; ENDOTHELIUM CELL; FETUS WASTAGE; GENE DELETION; GENE INACTIVATION; HISTOPATHOLOGY; HYDRAMNIOS; INNER EAR; MOUSE; NONHUMAN; PHENOTYPE; PLACENTA DEVELOPMENT; PLACENTA DISORDER; PROTEIN ANALYSIS; PROTEIN FUNCTION; TETRAPLOIDY; ANIMAL; FEMALE; GENETICS; MALE; METABOLISM; MOUSE MUTANT; PLACENTA; PREGNANCY; PRENATAL DEVELOPMENT;

ANIMALIA; MURINAE; MUS;

ANIMALS; ENDOTHELIAL CELLS; FEMALE; MALE; MICE; MICE, KNOCKOUT; PLACENTA; PREGNANCY; TRPP CATION CHANNELS;

EID: 77958595473     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012821     Document Type: Article

References (47)

1. Gabow PA (1993) Autosomal dominant polycystic kidney disease. N Engl J Med 329: 332-342.
2. Parfrey PS, Bear JC, Morgan J, Cramer BC, McManamon PJ, et al. (1990) The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med 323: 1085-1090.
3. Pirson Y. Extrarenal manifestations of autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 17: 173-180.
4. Harris PC, Torres VE (2009) Polycystic kidney disease. Annu Rev Med 60: 321-337.
5. Gallagher AR, Germino GG, Somlo S. Molecular advances in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 17: 118-130.
6. Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, et al. (2003) Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 33: 129-137.
7. Nauli SM, Kawanabe Y, Kaminski JJ, Pearce WJ, Ingber DE, et al. (2008) Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1. Circulation 117: 1161-1171.
8. AbouAlaiwi WA, Takahashi M, Mell BR, Jones TJ, Ratnam S, et al. (2009) Ciliary polycystin-2 is a mechanosensitive calcium channel involved in nitric oxide signaling cascades. Circ Res 104: 860-869.
9. Baert L (1978) Hereditary polycystic kidney disease (adult form): a microdissection study of two cases at an early stage of the disease. Kidney Int 13: 519-525.
10. Watnick T, He N,Wang K, Liang Y, Parfrey P, et al. (2000) Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations. Nat Genet 25: 143-144.
11. Pei Y, Watnick T, He N, Wang K, Liang Y, et al. (1999) Somatic PKD2 mutations in individual kidney and liver cysts support a "two-hit" model of cystogenesis in type 2 autosomal dominant polycystic kidney disease. J Am Soc Nephrol 10: 1524-1529.
12. Peters DJ, Sandkuijl LA (1992) Genetic heterogeneity of polycystic kidney disease in Europe. Contrib Nephrol 97: 128-139.
13. Qian F, Watnick TJ, Onuchic LF, Germino GG (1996) The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 87: 979-987.
14. Wu G, D'Agati V, Cai Y, Markowitz G, Park JH, et al. (1998) Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 93: 177-188.
15. Piontek KB, Huso DL, Grinberg A, Liu L, Bedja D, et al. (2004) A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo. J Am Soc Nephrol 15: 3035-3043.
16. Lu W, Fan X, Basora N, Babakhanlou H, Law T, et al. (1999) Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes. Nat Genet 21: 160-161.
17. Piontek K, Menezes LF, Garcia-Gonzalez MA, Huso DL, Germino GG (2007) A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat Med 13: 1490-1495.
18. Boulter C, Mulroy S, Webb S, Fleming S, Brindle K, et al. (2001) Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene. Proc Natl Acad Sci U S A 98: 12174-12179.
19. Lu W, Peissel B, Babakhanlou H, Pavlova A, Geng L, et al. (1997) Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation. Nat Genet 17: 179-181.
20. Kim K, Drummond I, Ibraghimov-Beskrovnaya O, Klinger K, Arnaout MA (2000) Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci U S A 97: 1731-1736.
21. Muto S, Aiba A, Saito Y, Nakao K, Nakamura K, et al. (2002) Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant. Hum Mol Genet 11: 1731-1742.
22. Wu G, Markowitz GS, Li L, D'Agati VD, Factor SM, et al. (2000) Cardiac defects and renal failure in mice with targeted mutations in Pkd2. Nat Genet 24: 75-78.
23. Pennekamp P, Karcher C, Fischer A, Schweickert A, Skryabin B, et al. (2002) The ion channel polycystin-2 is required for left-right axis determination in mice. Curr Biol 12: 938-943.
24. Paterson AD, Wang KR, Lupea D, St George-Hyslop P, Pei Y (2002) Recurrent fetal loss associated with bilineal inheritance of type 1 autosomal dominant polycystic kidney disease. Am J Kidney Dis 40: 16-20.
25. Guay-Woodford LM (2003) Murine models of polycystic kidney disease: molecular and therapeutic insights. Am J Physiol Renal Physiol 285: F1034-1049.
26. Qian Q, Li M, Cai Y, Ward CJ, Somlo S, et al. (2003) Analysis of the polycystins in aortic vascular smooth muscle cells. J Am Soc Nephrol 14: 2280-2287.
27. Gonzalez-Perrett S, Kim K, Ibarra C, Damiano AE, Zotta E, et al. (2001) Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci U S A 98: 1182-1187.
28. Ong AC, Ward CJ, Butler RJ, Biddolph S, Bowker C, et al. (1999) Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue. Am J Pathol 154: 1721-1729.
29. Ohlsson R, Falck P, Hellstrom M, Lindahl P, Bostrom H, et al. (1999) PDGFB regulates the development of the labyrinthine layer of the mouse fetal placenta. Dev Biol 212: 124-136.
30. Allen E, Piontek KB, Garrett-Mayer E, Garcia-Gonzalez M, Gorelick KL, et al. (2006) Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors. Hum Mol Genet 15: 11-21.
31. James RM, Klerkx AH, Keighren M, Flockhart JH, West JD (1995) Restricted distribution of tetraploid cells in mouse tetraploid,= =.diploid chimaeras. Dev Biol 167: 213-226.
32. Tallquist MD, Soriano P (2000) Epiblast-restricted Cre expression in MORE mice: a tool to distinguish embryonic vs. extra-embryonic gene function. Genesis 26: 113-115.
33. Soriano P (1999) Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21: 70-71.
34. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, et al. (2001) Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol 230: 230-242.
35. Lobe CG, Koop KE, Kreppner W, Lomeli H, Gertsenstein M, et al. (1999) Z/ AP, a double reporter for cre-mediated recombination. Dev Biol 208: 281-292.
36. Watson ED, Cross JC (2005) Development of structures and transport functions in the mouse placenta. Physiology (Bethesda) 20: 180-193.
37. Rossant J, Cross JC (2001) Placental development: lessons from mouse mutants. Nat Rev Genet 2: 538-548.
38. Beall MH, van den Wijngaard JP, van Gemert MJ, Ross MG (2007) Regulation of amniotic fluid volume. Placenta 28: 824-832.
39. Ahrabi AK, Jouret F, Marbaix E, Delporte C, Horie S, et al. Glomerular and proximal tubule cysts as early manifestations of Pkd1 deletion. Nephrol Dial Transplant 25: 1067-1078.
40. Zamboni L, Upadhyay S (1981) Ephemeral, rudimentary glomerular structures in the mesonephros of the mouse. Anat Rec 201: 641-644.
41. Cattelino A, Liebner S, Gallini R, Zanetti A, Balconi G, et al. (2003) The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility. J Cell Biol 162: 1111-1122.
42. Allende ML, Yamashita T, Proia RL (2003) G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood 102: 3665-3667.
43. Fu J, Gerhardt H, McDaniel JM, Xia B, Liu X, et al. (2008) Endothelial cell Oglycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J Clin Invest 118: 3725-3737.
44. Srinivasan RS, Dillard ME, Lagutin OV, Lin FJ, Tsai S, et al. (2007) Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes Dev 21: 2422-2432.
45. Bhunia AK, Piontek K, Boletta A, Liu L, Qian F, et al. (2002) PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 109: 157-168.
46. Yu S, Hackmann K, Gao J, He X, Piontek K, et al. (2007) Essential role of cleavage of Polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure. Proc Natl Acad Sci U S A 104: 18688-18693.
47. Boletta A, Qian F, Onuchic LF, Bhunia AK, Phakdeekitcharoen B, et al. (2000) Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells. Mol Cell 6: 1267-1273.